TY - JOUR
T1 - Exploring Heteroaromatic Rings as a Replacement for the Labile Amide of Antiplasmodial Pantothenamides
AU - Guan, Jinming
AU - Spry, Christina
AU - Tjhin, Erick T.
AU - Yang, Penghui
AU - Kittikool, Tanakorn
AU - Howieson, Vanessa M.
AU - Ling, Harriet
AU - Starrs, Lora
AU - Duncan, Dustin
AU - Burgio, Gaetan
AU - Saliba, Kevin J.
AU - Auclair, Karine
N1 - Publisher Copyright:
© 2021 American Chemical Society. All rights reserved.
PY - 2021/4/22
Y1 - 2021/4/22
N2 - Malaria-causing Plasmodium parasites are developing resistance to antimalarial drugs, providing the impetus for new antiplasmodials. Although pantothenamides show potent antiplasmodial activity, hydrolysis by pantetheinases/vanins present in blood rapidly inactivates them. We herein report the facile synthesis and biological activity of a small library of pantothenamide analogues in which the labile amide group is replaced with a heteroaromatic ring. Several of these analogues display nanomolar antiplasmodial activity against Plasmodium falciparum and/or Plasmodium knowlesi, and are stable in the presence of pantetheinase. Both a known triazole and a novel isoxazole derivative were further characterized and found to possess high selectivity indices, medium or high Caco-2 permeability, and medium or low microsomal clearance in vitro. Although they fail to suppress Plasmodium berghei proliferation in vivo, the pharmacokinetic and contact time data presented provide a benchmark for the compound profile likely required to achieve antiplasmodial activity in mice and should facilitate lead optimization.
AB - Malaria-causing Plasmodium parasites are developing resistance to antimalarial drugs, providing the impetus for new antiplasmodials. Although pantothenamides show potent antiplasmodial activity, hydrolysis by pantetheinases/vanins present in blood rapidly inactivates them. We herein report the facile synthesis and biological activity of a small library of pantothenamide analogues in which the labile amide group is replaced with a heteroaromatic ring. Several of these analogues display nanomolar antiplasmodial activity against Plasmodium falciparum and/or Plasmodium knowlesi, and are stable in the presence of pantetheinase. Both a known triazole and a novel isoxazole derivative were further characterized and found to possess high selectivity indices, medium or high Caco-2 permeability, and medium or low microsomal clearance in vitro. Although they fail to suppress Plasmodium berghei proliferation in vivo, the pharmacokinetic and contact time data presented provide a benchmark for the compound profile likely required to achieve antiplasmodial activity in mice and should facilitate lead optimization.
UR - http://www.scopus.com/inward/record.url?scp=85104907401&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.0c01755
DO - 10.1021/acs.jmedchem.0c01755
M3 - Article
SN - 0022-2623
VL - 64
SP - 4478
EP - 4497
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 8
ER -